Biopharmaceutical CMO and CRO Market Overview 2030
A contract manufacturing organization (CMO) is an organization that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services for new drug developments through drug manufacturing. This helps the major pharmaceutical companies to outsource those aspects of the business which allow major companies to focus on drug discovery and drug marketing.
A contract research organization (CRO) is an organization that provides support to the pharmaceutical, biotechnological, and medical device industries in the form of research services which are on contract basis. Contract research organization provide services such as biopharmaceutical development, biological assay development, commercialization, preclinical research, clinical trials, and pharmacovigilance.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the biopharmaceutical CMO and CRO market.
Top Impacting Factors
- Increase in demand for novel therapeutics, rise in integration of single-use systems in production facilities, surge in incidence of chronic diseases, increase in production rate of drugs, and rise in demand for biosimilars products in market is expected to drive the growth of the market.
- In addition, increase in adoption of advance healthcare information technology sector, surge in usage of outsourcing activities, rise in expenditure to build modern infrastructures, increase in R & D activities to improve technology in biopharmaceutical sector, and surge in drug discovery & drug development procedures are some factors that fuel the growth of the biopharmaceutical CMO and CRO market.
- However, high cost of biopharmaceutical CMO & CRO services and data security threats restrain the growth of the biopharmaceutical CMO and CRO market.
- Contrarily, rise in demand for contract research and contract manufacturing organization is expected to offer lucrative opportunities for the expansion of the market.
Market Trends
Business Expansion to Flourish the Market
In 2020, J-Star Research Inc., announced launch of new website which will help company to lead in contract research organization focused on small molecule process research and crystallization R & D.
In 2019, ANI Pharmaceuticals announced merger with WellSpring Pharma expansion of contract manufacturing organization. This expansion will help ANI pharmaceuticals to speed up drug development and drug manufacturing process
Key Benefits of the Report
- This study presents the analytical depiction of biopharmaceutical CMO and CRO market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the biopharmaceutical CMO and CRO market share.
- The current market is quantitatively analyzed to highlight the biopharmaceutical CMO and CRO market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Biopharmaceutical CMO and CRO Market Report
- Which are the leading players active in the biopharmaceutical CMO and CRO market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is "biopharmaceutical CMO and CRO"?
- What is "biopharmaceutical CMO and CRO" market prediction in the future?
- Who are the leading global players in the "biopharmaceutical CMO and CRO" market?
- What are the current trends and predicted trends?
- What are the key benefits of the "biopharmaceutical CMO and CRO" market report?
Biopharmaceutical CMO and CRO Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Source |
|
 By Service Type |
|
 By Region |
|
 Key Market Players | Rentschler Biotechnologie GmbH, TOYOBO CO., LTD., Samsung BioLogics, ProBioGen, BIOMEVA GmbH, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim GmbH, Lonza, JRS PHARMA, Inno Biologics Sdn Bhd |
Loading Table Of Content...
